SUBJECTS : Medicine | Clinical Medicine | Translational Medicine | Diseas
LATEST MANUSCRIPTS IN Cell Reports Medicine
- Paul Régnier, Mathias Vetillard, Adèle Bansard, Eméranne Pierre, Xinyue Li, Nicolas Cagnard, Emmanuel L Gautier, Pierre Guermonprez, Bénédicte Manoury, Katrina Podsypanina, Guillaume Darrasse-Jèze. FLT3L-dependent dendritic cells control tumor immunity by modulating Treg and NK cell homeostasis. Cell reports. Medicine. 2023, 4 (12): 101256
Cited : 3Read More - Jordan D Philpott, Jordan Miller, Brittany P Boribong, Saeina Charles, Jameson P Davis, Simon Kazimierczyk, Brittany Jimena, Maureen M Leonard, Wayne G Shreffler, Alessio Fasano, Lael M Yonker, Nitya Jain. Antigen-specific T cell responses in SARS-CoV-2 mRNA-vaccinated children. Cell reports. Medicine. 2023, 4 (12): 101298Cited : 0Read More
- Flore Sinturel, Simona Chera, Marie-Claude Brulhart-Meynet, Jonathan Paz Montoya, Dirk Jan Stenvers, Peter H Bisschop, Andries Kalsbeek, Idris Guessous, François R Jornayvaz, Jacques Philippe, Steven A Brown, Giovanni D'Angelo, Howard Riezman, Charna Dibner. Circadian organization of lipid landscape is perturbed in type 2 diabetic patients. Cell reports. Medicine. 2023, 4 (12): 101299Cited : 2Read More
- Bo Zhang, Yan Song, Suxia Luo, Xianli Yin, Enxiao Li, Hui Wang, Yifu He, Zhihui Liu, Qingxia Fan, Xinjun Liang, Yongqian Shu, Yunpeng Liu, Nong Xu, Shu Zhang, Zhixiang Zhuang, Jingdong Zhang, Xiaoge Kou, Fen Wang, Xiaodong Zhu, Shan Zeng, Ke Wang, Haijun Zhong, Shengmian Li, Yuxian Bai, Junyan Yu, Yiwei Dou, Taiyang Ma, Qian Liu, Jing Huang. Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. Cell reports. Medicine. 2023, 4 (12): 101301Cited : 0Read More
- Jianchun Duan, Yun Zhang, Ran Chen, Liang Liang, Yi Huo, Shun Lu, Jun Zhao, Chunhong Hu, Yuping Sun, Kunyu Yang, Mingwei Chen, Yan Yu, Jianming Ying, Ruiqi Huang, Xiaopeng Ma, Shiangjiin Leaw, Fan Bai, Zhirong Shen, Shangli Cai, Daming Gao, Jie Wang, Zhijie Wang. Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma. Cell reports. Medicine. 2023, 4 (12): 101302Cited : 1Read More
- Yajie Sun, Yu Tian, Shuhui Wu, Ai Huang, Yan Hu, Zhiyun Liao, Michelle Swift, Suke Deng, Xiao Yang, Bin Zhang, Zhanjie Zhang, Bian Wu, Jing Huang, Ke Jiang, Fang Huang, Honglin Jin, Chao Wan, Kunyu Yang. Engineering irradiated tumor-derived microparticles as personalized vaccines to enhance anti-tumor immunity. Cell reports. Medicine. 2023, 4 (12): 101303Cited : 2Read More
- Qingtian Zhu, Chenchen Yuan, Xiaowu Dong, Yaodong Wang, Baiqiang Li, Bo Tu, Weiwei Chen, Xingmeng Xu, Weijuan Gong, Weiming Xiao, Yanbing Ding, Lianghao Hu, Weiqin Li, Guotao Lu. Bile acid metabolomics identifies chenodeoxycholic acid as a therapeutic agent for pancreatic necrosis. Cell reports. Medicine. 2023, 4 (12): 101304Cited : 6Read More
- Lucas J Adams, Laura A VanBlargan, Zhuoming Liu, Pavlo Gilchuk, Haiyan Zhao, Rita E Chen, Saravanan Raju, Zhenlu Chong, Bradley M Whitener, Swathi Shrihari, Prashant N Jethva, Michael L Gross, James E Crowe, Sean P J Whelan, Michael S Diamond, Daved H Fremont. A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protection. Cell reports. Medicine. 2023, 4 (12): 101305Cited : 3Read More
- Erica Mina, Elisabeth Wyart, Roberta Sartori, Elia Angelino, Ivan Zaggia, Valentina Rausch, Mara Maldotti, Alessia Pagani, Myriam Y Hsu, Alberto Friziero, Cosimo Sperti, Alessio Menga, Andrea Graziani, Emilio Hirsch, Salvatore Oliviero, Marco Sandri, Laura Conti, Léon Kautz, Laura Silvestri, Paolo E Porporato. FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy. Cell reports. Medicine. 2023, 4 (12): 101306Cited : 1Read More
- Jenna H Rannikko, Loic Verlingue, Maria de Miguel, Annika Pasanen, Debbie Robbrecht, Tanja Skytta, Sanna Iivanainen, Shishir Shetty, Yuk Ting Ma, Donna M Graham, Sukeshi Patel Arora, Panu Jaakkola, Christina Yap, Yujuan Xiang, Jami Mandelin, Matti K Karvonen, Juho Jalkanen, Sinem Karaman, Jussi P Koivunen, Anna Minchom, Maija Hollmén, Petri Bono. Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial. Cell reports. Medicine. 2023, 4 (12): 101307Cited : 6Read More
- Altair Brito Dos Santos, Silas Dalum Larsen, Liangchen Guo, Paola Barbagallo, Alexia Montalant, Matthijs Verhage, Jakob Balslev Sørensen, Jean-François Perrier. Microcircuit failure in STXBP1 encephalopathy leads to hyperexcitability. Cell reports. Medicine. 2023, 4 (12): 101308Cited : 1Read More
- Yenal B Lakes, Stefanie L Moye, Juan Mo, Matthew Tegtmeyer, Ralda Nehme, Maura Charlton, Gabrielle Salinas, Renee M McKay, Kevin Eggan, Lu Q Le. Econazole selectively induces cell death in NF1-homozygous mutant tumor cells. Cell reports. Medicine. 2023, 4 (12): 101309Cited : 0Read More
- Xiangyu Jin, Didi Liu, Xinru Zhou, Xianyu Luo, Qian Huang, Yi Huang. Entrectinib inhibits NLRP3 inflammasome and inflammatory diseases by directly targeting NEK7. Cell reports. Medicine. 2023, 4 (12): 101310Cited : 4Read More
- Yan Li, Bing Wang, Fahan Ma, Dongxian Jiang, Ying Wang, Kai Li, Subei Tan, Jinwen Feng, Yunzhi Wang, Zhaoyu Qin, Ganfei Xu, Sha Tian, Xiaolei Zhang, Chen Xu, Jiaxue Wu, Jianmin Xu, Yingyong Hou, Chen Ding. Proteomic characterization of the colorectal cancer response to chemoradiation and targeted therapies reveals potential therapeutic strategies. Cell reports. Medicine. 2023, 4 (12): 101311Cited : 2Read More
- Rosa I Gallagher, Julia Wulfkuhle, Denise M Wolf, Lamorna Brown-Swigart, Christina Yau, Nicholas O'Grady, Amrita Basu, Ruixiao Lu, Michael J Campbell, Mark J Magbanua, Jean-Philippe Coppé, , Smita M Asare, Laura Sit, Jeffrey B Matthews, Jane Perlmutter, Nola Hylton, Minetta C Liu, W Fraser Symmans, Hope S Rugo, Claudine Isaacs, Angela M DeMichele, Douglas Yee, Paula R Pohlmann, Gillian L Hirst, Laura J Esserman, Laura J van 't Veer, Emanuel F Petricoin. Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 Trial. Cell reports. Medicine. 2023, 4 (12): 101312Cited : 5Read More
